These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35435111)

  • 1. Radiation-induced prostate swelling during SBRT of the prostate.
    Vanhanen A; Reinikainen P; Kapanen M
    Acta Oncol; 2022 Jun; 61(6):698-704. PubMed ID: 35435111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
    Marnouche EA; Hadadi K; Abdelhak M; Benlemlih M; Hommadi M; Zaghba N; Andaloussi Saghir K; Elmarjany M; Sifat H; Mansouri H
    Cancer Radiother; 2021 Apr; 25(2):161-168. PubMed ID: 33454191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.
    Ma TM; Neylon J; Casado M; Sharma S; Sheng K; Low D; Yang Y; Steinberg ML; Lamb J; Cao M; Kishan AU
    Radiother Oncol; 2022 Feb; 167():203-210. PubMed ID: 34979212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity.
    Nicosia L; Ravelli P; Rigo M; Giaj-Levra N; Mazzola R; Pastorello E; Ricchetti F; Allegra AG; Ruggieri R; Alongi F
    Radiother Oncol; 2024 Jan; 190():110043. PubMed ID: 38056694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer.
    Tinger A; Michalski JM; Cheng A; Low DA; Zhu R; Bosch WR; Purdy JA; Perez CA
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):213-21. PubMed ID: 9747840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
    Fukuda S; Seo Y; Shiomi H; Yamada Y; Ogata T; Morimoto M; Konishi K; Yoshioka Y; Ogawa K
    J Radiat Res; 2014 Nov; 55(6):1114-21. PubMed ID: 24957754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.
    Zelefsky MJ; Crean D; Mageras GS; Lyass O; Happersett L; Ling CC; Leibel SA; Fuks Z; Bull S; Kooy HM; van Herk M; Kutcher GJ
    Radiother Oncol; 1999 Feb; 50(2):225-34. PubMed ID: 10368047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-ventilation based PTV margins in Stereotactic Body Radiotherapy (SBRT): a clinical evaluation.
    Peulen H; Belderbos J; Rossi M; Sonke JJ
    Radiother Oncol; 2014 Mar; 110(3):511-6. PubMed ID: 24560765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
    Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
    Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transperineal ultrasound is a good alternative for intra-fraction motion monitoring for prostate stereotactic body radiotherapy.
    Guo B; Stephans K; Godley A; Kolar M; Magnelli A; Tendulkar R; Mian O; Majkszak D; Xia P
    J Appl Clin Med Phys; 2023 Oct; 24(10):e14021. PubMed ID: 37144947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer?
    Góra J; Stock M; Lütgendorf-Caucig C; Georg D
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):881-8. PubMed ID: 22818417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.
    Ruggieri R; Rigo M; Naccarato S; Gurrera D; Figlia V; Mazzola R; Ricchetti F; Nicosia L; Giaj-Levra N; Cuccia F; Vitale C; Stavreva N; Pressyanov DS; Stavrev P; Pellegrini R; Alongi F
    Phys Med; 2020 Dec; 80():34-41. PubMed ID: 33091796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.
    Bellec J; Arab-Ceschia F; Castelli J; Lafond C; Chajon E
    Radiat Oncol; 2020 Mar; 15(1):54. PubMed ID: 32127010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
    Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
    Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system.
    Zahir NSM; Saad M; Alip A; Rejab M; Jamalludin Z; Hizam NDA; Liew YM; Ung NM
    Phys Eng Sci Med; 2023 Mar; 46(1):405-412. PubMed ID: 36806157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
    Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study.
    Westley RL; Alexander SE; Goodwin E; Dunlop A; Nill S; Oelfke U; McNair HA; Tree AC
    Front Oncol; 2024; 14():1379596. PubMed ID: 38894866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric-based image guidance is superior to marker-based alignments for stereotactic body radiotherapy of prostate cancer.
    Li W; Lu L; Stephans KL; Sharma N; Vassil A; Shen ZL; Stockham A; Djemil T; Tendulkar RD; Xia P
    J Appl Clin Med Phys; 2018 Mar; 19(2):198-203. PubMed ID: 29450961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.